甲基化帽结合蛋白2:系统性硬化症中的关键表观遗传蛋白
该研究探讨MeCP2在系统性硬化症(SSc)皮肤纤维化中的作用,使用健康与SSc真皮成纤维细胞,通过siRNA沉默和慢病毒过表达以及免疫印迹检测。结果显示TGF-β1诱导正常细胞MeCP2表达,SSc成纤维细胞基础水平MeCP2高表达;MeCP2通过表观遗传抑制Wnt拮抗剂sFRP-1增强Wnt信号,并经糖酵解介导纤维化;miR132在SSc成纤维细胞中表达降低。结论提示存在介导纤维化的表观遗传环路,靶向MeCP2或糖酵解代谢重编程可能是有前景的治疗途径。
要点
- SSc真皮成纤维细胞基础状态下MeCP2表达升高,TGF-β1可诱导正常成纤维细胞MeCP2表达。
- MeCP2通过表观遗传抑制sFRP-1增强Wnt信号,并经糖酵解促进胶原表达。
- 靶向MeCP2或需氧糖酵解代谢重编程可能成为SSc纤维化的治疗策略。
核心结论
- SSc中存在一个表观遗传环路介导纤维化,MeCP2作为关键表观遗传调控因子可能成为治疗靶点。
- 靶向MeCP2或靶向需氧糖酵解导致的代谢重编程可能是有前景的治疗途径。
研究设计与样本
- 研究使用健康与SSc真皮成纤维细胞,通过小干扰RNA沉默和慢病毒过表达MeCP2以确定其作用。
- 通过免疫印迹检测SSc成纤维细胞中MeCP2表达,通过Taqman实时PCR定量miRNA132。
主要发现
- TGF-β1诱导正常细胞中MeCP2表达,SSc成纤维细胞在基础条件下表达高水平MeCP2。
- MeCP2通过表观遗传抑制Wnt拮抗剂sFRP-1正调控细胞外基质表达,导致Wnt信号增强。
- 糖酵解抑制剂2-脱氧葡萄糖减弱Wnt介导的胶原表达,提示纤维化通过糖酵解介导。
- SSc成纤维细胞中miR132表达降低。
临床怎么用
- MeCP2及其下游Wnt/糖酵解通路可作为SSc纤维化的潜在干预靶点,但尚需进一步临床转化研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: SSc is an autoimmune connective tissue disease that results in skin fibrosis and currently has no effective treatment. Epigenetic modifications have been described and these may be key in initiating and driving fibroblast activation. Among these epigenetic modifications methylation may be of central importance. The aim of this study was to examine the role of methyl cap binding protein-2 (MeCP2) in SSc fibrosis. METHODS: We used healthy and SSc dermal fibroblasts to examine the role of MeCP2, using both small interfering RNA silencing and lentiviral overexpression to determine its effects. We also examined the expression of MeCP2 in SSc fibroblasts by immunoblotting. miRNA132 was quantified by Taqman real time PCR. RESULTS: We demonstrated that TGF-β1 induced the expression of MeCP2 in normal cells, and showed that SSc fibroblasts expressed high levels of MeCP2 under basal conditions. MeCP2 positively regulated the expression of extracellular matrix through epigenetic repression of the Wnt antagonist sFRP-1, leading to enhanced Wnt signalling. This mediated fibrosis through glycolysis, as the glycolysis inhibitor 2-deoxyglucose diminished the Wnt-mediated collagen expression. MiR132 expression was reduced in SSc fibroblasts. CONCLUSION: The results suggest that an epigenetic loop exists mediating fibrosis. Targeting of MeCP2, as a key epigenetic regulator, may be a promising therapeutic approach, as would targeting the metabolic reprogramming that occurs through aerobic glycolysis.
引用
- Henderson J, Brown M, Horsburgh S, et al. Methyl cap binding protein 2: a key epigenetic protein in systemic sclerosis. Rheumatology (Oxford). 2019. PMID: 30462328. doi:10.1093/rheumatology/key327
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。